Esperion Therapeutics
ESPR
#6513
Rank
NZ$1.49 B
Marketcap
NZ$5.79
Share price
0.00%
Change (1 day)
33.71%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2026 (TTM): NZ-$0.03368

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$0.03640. In 2025 the company made an earnings per share (EPS) of NZ-$0.24 an increase over its 2024 EPS that were of NZ-$0.42.

EPS history for Esperion Therapeutics from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$0.03368-85.77%
2025NZ-$0.24-43.48%
2024NZ-$0.42-89.15%
2023NZ-$3.86-40.28%
2022NZ-$6.46-62.87%
2021NZ-$17.4080.38%
2020NZ-$9.6450.14%
2019NZ-$6.42-53.18%
2018NZ-$13.727.41%
2017NZ-$12.77110.81%
2016NZ-$6.0647.35%
2015NZ-$4.110.89%
2014NZ-$4.08

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$1.29-3,650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$85.49-235,000.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
NZ-$9.44 25,850.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
NZ-$0.25 600.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ-$0.20 450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ-$0.16 350.00%๐Ÿ‡บ๐Ÿ‡ธ USA